Baker JN - Search Results

1

Palliative Sedation Therapy in Pediatrics: An Algorithm and Clinical Practice Update.

Cuviello A, Johnson LM, Morgan KJ, Anghelescu DL, Baker JN. Cuviello A, et al. Among authors: baker jn. Children (Basel). 2022 Dec 1;9(12):1887. doi: 10.3390/children9121887. Children (Basel). 2022. PMID: 36553328 Free PMC article.

2

Pain still lords over children.

Baker JN, Anghelescu DL, Kane JR. Baker JN, et al. J Pediatr. 2008 Jan;152(1):6-8. doi: 10.1016/j.jpeds.2007.08.019. J Pediatr. 2008. PMID: 18154888 No abstract available.

3

Use of epidural and peripheral nerve blocks at the end of life in children and young adults with cancer: the collaboration between a pain service and a palliative care service.

Anghelescu DL, Faughnan LG, Baker JN, Yang J, Kane JR. Anghelescu DL, et al. Among authors: baker jn. Paediatr Anaesth. 2010 Dec;20(12):1070-7. doi: 10.1111/j.1460-9592.2010.03449.x. Paediatr Anaesth. 2010. PMID: 21199115 Free PMC article.

4

Pediatric palliative sedation therapy with propofol: recommendations based on experience in children with terminal cancer.

Anghelescu DL, Hamilton H, Faughnan LG, Johnson LM, Baker JN. Anghelescu DL, et al. Among authors: baker jn. J Palliat Med. 2012 Oct;15(10):1082-90. doi: 10.1089/jpm.2011.0500. Epub 2012 Jun 25. J Palliat Med. 2012. PMID: 22731512 Free PMC article.

5

An unusual case of Ogilvie syndrome in a pediatric oncology patient receiving palliative care after failed treatment with neostigmine.

Johnson LM, Spraker HL, Coleman JL, Baker JN. Johnson LM, et al. Among authors: baker jn. J Palliat Med. 2012 Sep;15(9):1042-6. doi: 10.1089/jpm.2011.0450. J Palliat Med. 2012. PMID: 22946581

6

Clinically significant? Depends on whom you ask.

Johnson LM, Church CL, Walsh MF, Baker JN. Johnson LM, et al. Among authors: baker jn. Am J Bioeth. 2012;12(10):18-20. doi: 10.1080/15265161.2012.699159. Am J Bioeth. 2012. PMID: 22974023 No abstract available.

7

End-of-life care for hospitalized children.

Johnson LM, Snaman JM, Cupit MC, Baker JN. Johnson LM, et al. Among authors: baker jn. Pediatr Clin North Am. 2014 Aug;61(4):835-54. doi: 10.1016/j.pcl.2014.04.012. Pediatr Clin North Am. 2014. PMID: 25084727 Review.

8

Does phase 1 trial enrollment preclude quality end-of-life care? Phase 1 trial enrollment and end-of-life care characteristics in children with cancer.

Levine DR, Johnson LM, Mandrell BN, Yang J, West NK, Hinds PS, Baker JN. Levine DR, et al. Among authors: baker jn. Cancer. 2015 May 1;121(9):1508-12. doi: 10.1002/cncr.29230. Epub 2014 Dec 29. Cancer. 2015. PMID: 25557437 Free PMC article.

9

Patient-controlled analgesia at the end of life at a pediatric oncology institution.

Anghelescu DL, Snaman JM, Trujillo L, Sykes AD, Yuan Y, Baker JN. Anghelescu DL, et al. Among authors: baker jn. Pediatr Blood Cancer. 2015 Jul;62(7):1237-44. doi: 10.1002/pbc.25493. Epub 2015 Mar 27. Pediatr Blood Cancer. 2015. PMID: 25820345 Free PMC article.

10

Practical communication guidance to improve phase 1 informed consent conversations and decision-making in pediatric oncology.

Johnson LM, Leek AC, Drotar D, Noll RB, Rheingold SR, Kodish ED, Baker JN. Johnson LM, et al. Among authors: baker jn. Cancer. 2015 Jul 15;121(14):2439-48. doi: 10.1002/cncr.29354. Epub 2015 Apr 14. Cancer. 2015. PMID: 25873253 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

279 results

Search Page